[1]
Ju, R., Chen, X., Zhang, S., Liu, B., Pei, H., Tu, F., Liu, J. and Yu, H. 2021. Plasma exosome-derived fragile-site associated tumor suppressor is a powerful predictor of prognosis in patients with ovarian cancer. Bosnian Journal of Basic Medical Sciences. (Sep. 2021). DOI:https://doi.org/10.17305/bjbms.2021.6404.